Company Filing History:
Years Active: 2019-2025
Title: Glen Mathew Boyle: Innovator in Cancer Treatment
Introduction
Glen Mathew Boyle is a notable inventor based in Taringa, Australia. He has made significant contributions to the field of cancer treatment through his innovative methods and pharmaceutical compositions. With a total of 5 patents, Boyle's work focuses on advancing therapeutic options for patients battling tumors.
Latest Patents
Boyle's latest patents include groundbreaking methods for treating tumors. One of his inventions is a method of treating tumors that involves the localized administration of an epoxytiglienone compound. This method aims to generate a systemic anticancer abscopal and/or bystander effect. Another significant patent is a combination therapy for the treatment or prevention of tumors, which includes the administration of an epoxytigliane compound alongside an immune checkpoint inhibitor. This innovative approach not only targets the primary tumor but also aims to treat or prevent bystander tumors.
Career Highlights
Throughout his career, Glen Mathew Boyle has worked with reputable companies such as Qbiotics Pty Ltd and Qbiotics Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in cancer treatment.
Collaborations
Boyle has collaborated with esteemed colleagues, including Paul Warren Reddell and Peter Gordon Parsons. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Glen Mathew Boyle's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to inspire advancements in the medical field, showcasing the importance of innovation in healthcare.